Artritis Idiopática Juvenil
Palabras clave:
Artritis idiopática juvenil, clasificación, espondiloartropatías juveniles, diagnóstico, tratamiento.Resumen
La Artritis Idiopática Juvenil (AIJ), es un término que describe a un grupo heterogéneo de artritis inflamatoria crónica, que ocurre en personas menores de 16 años de edad, tiene una duración de 6 semanas o más, y donde otras patologías han sido excluidas. El propósito de esta revisión es presentar los cambios en la clasificación y diagnóstico, y mencionar algunos aspectos en el tratamiento de la Artritis Idiopática Juvenil, a fin de lograr un mayor conocimiento de esta patología, en cuyo seguimiento intervienen de manera multidisciplinaria el pediatra, el reumatólogo infantil, el fisiatra, el traumatólogo, el psicólogo y los especialistas de sistemas afectados.
Métricas
Cargando métricas ...
Citas
1. Petty RE, Southwood TR, Manners P. International league of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-92. [ Links ]
2. Cassidy JT, Petty RE. Chronic arthritis in childhood. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.206-260. [ Links ]
3. Lopez-Benitez JM, Miller LC, Schaller JG, Moreno LM, Espinola M. Erroneous diasgnoses in children referred with acute rheumatic fever. Pediatr Infect Dis J. 2008;27(2):181-82. [ Links ]
4. Petty RE, Cassidy JT. Polyarthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.261-273. [ Links ]
5. Petty RE, Cassidy J.T. Oligoarthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.274-290. [ Links ]
6. Petty RE, Cassidy JT. Systemic arthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.291-303. [ Links ]
7. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management and outcome. Nat Clin Pract Rheumatol. 2006;2:28-34. [ Links ]
8. Petty RE, Southwood TR. Psoriatic arthritis. En: Cassidy P, Laxer L, editores. Textbook of Pediatric Rheumatology, Elsevier-Saunders, 5ta Ed. Philadelphia; Elsevier; 2005: 324-333. [ Links ]
9. Cassidy JT, Petty RE. Juvenile ankylosing spondylitis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.304-323. [ Links ]
10. Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum. 2005;52:2103-2108. [ Links ]
11. Woo P. Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep. 2002;4(6):452-57. [ Links ]
12. Bloom BJ, Smith P, Alario AJ. Felty syndrome complicating juvenile rheumatoid arthritis. J Pediatr Hematol Oncol. 1998;20(5):511-13. [ Links ]
13. Chan-Hee L, Sung-Hun H, Bo-Young Y, Yun-Woo L. A case of adult-onset Felty syndrome in juvenile rheumatoid arthritis. Pediatr Int. 2005;47:463-65. [ Links ]
14. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19:477-81. [ Links ]
15. Tse SM, Laxer RM, Babyn PS. Radiologic improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following antitumor necrosis factor-alpha blockade with etanercept. J Rheumatol. 2006;33:1186-188. [ Links ]
16. Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin N Am. 2006;20:827-47. [ Links ]
17. Rodríguez S, Gámir ML. Espondiloartritis en la infancia: formas de presentación, diagnóstico y tratamiento. Reumatol Clin. 2007;3 Supl 2:S2-6. [ Links ]
18. Haines KA. Juvenile idiopathic arthritis: therapies in the 21st century. Bull NYU Hosp Jt Dis. 2007;65(3):205-11. [ Links ]
19. Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2008;20:613-18. [ Links ]
20. De-Inocencio J, Merino R, Álvarez C, García-Consuegra J. Efectividad del etanercept en el tratamiento de la artritis idiopática juvenil. An Pediatr (Barc). 2009;70(4):354-61. [ Links ]
21. Yokota S, Imagawa T, Mori M, Miyamae T. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998-1006. [ Links ]
22. Ruperto N, Lovell DJ, Quartier P, Paz E. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet. 2008;372(9636):383-91. [ Links ]
23. Zeft A, Hollister R, LaFleur B, Sampath P. Anakinra for systemic juvenile arthritis: the rocky mountain experience. J Clin Rheumatol. 2009;15(4):161-64. [ Links ]
24. Church LD, McDermott MF. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther. 2009;11(1):81-89. [ Links ]
25. Giannini E, Ruperto N, Ravelli A, Lovell D. Preliminary definition of improvement in juvenile artritis. Arthritis Rheum. 1997;40(7):1202-1209. [ Links ]
26. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol. 2002;29(5):1058-1064. [ Links ]
2. Cassidy JT, Petty RE. Chronic arthritis in childhood. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.206-260. [ Links ]
3. Lopez-Benitez JM, Miller LC, Schaller JG, Moreno LM, Espinola M. Erroneous diasgnoses in children referred with acute rheumatic fever. Pediatr Infect Dis J. 2008;27(2):181-82. [ Links ]
4. Petty RE, Cassidy JT. Polyarthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.261-273. [ Links ]
5. Petty RE, Cassidy J.T. Oligoarthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.274-290. [ Links ]
6. Petty RE, Cassidy JT. Systemic arthritis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.291-303. [ Links ]
7. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management and outcome. Nat Clin Pract Rheumatol. 2006;2:28-34. [ Links ]
8. Petty RE, Southwood TR. Psoriatic arthritis. En: Cassidy P, Laxer L, editores. Textbook of Pediatric Rheumatology, Elsevier-Saunders, 5ta Ed. Philadelphia; Elsevier; 2005: 324-333. [ Links ]
9. Cassidy JT, Petty RE. Juvenile ankylosing spondylitis. En: Cassidy P, Laxer L, editores. Textbook of pediatric rheumatology. 5ta ed. Philadelphia: Elsevier; 2005.p.304-323. [ Links ]
10. Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum. 2005;52:2103-2108. [ Links ]
11. Woo P. Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep. 2002;4(6):452-57. [ Links ]
12. Bloom BJ, Smith P, Alario AJ. Felty syndrome complicating juvenile rheumatoid arthritis. J Pediatr Hematol Oncol. 1998;20(5):511-13. [ Links ]
13. Chan-Hee L, Sung-Hun H, Bo-Young Y, Yun-Woo L. A case of adult-onset Felty syndrome in juvenile rheumatoid arthritis. Pediatr Int. 2005;47:463-65. [ Links ]
14. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19:477-81. [ Links ]
15. Tse SM, Laxer RM, Babyn PS. Radiologic improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following antitumor necrosis factor-alpha blockade with etanercept. J Rheumatol. 2006;33:1186-188. [ Links ]
16. Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin N Am. 2006;20:827-47. [ Links ]
17. Rodríguez S, Gámir ML. Espondiloartritis en la infancia: formas de presentación, diagnóstico y tratamiento. Reumatol Clin. 2007;3 Supl 2:S2-6. [ Links ]
18. Haines KA. Juvenile idiopathic arthritis: therapies in the 21st century. Bull NYU Hosp Jt Dis. 2007;65(3):205-11. [ Links ]
19. Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2008;20:613-18. [ Links ]
20. De-Inocencio J, Merino R, Álvarez C, García-Consuegra J. Efectividad del etanercept en el tratamiento de la artritis idiopática juvenil. An Pediatr (Barc). 2009;70(4):354-61. [ Links ]
21. Yokota S, Imagawa T, Mori M, Miyamae T. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998-1006. [ Links ]
22. Ruperto N, Lovell DJ, Quartier P, Paz E. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet. 2008;372(9636):383-91. [ Links ]
23. Zeft A, Hollister R, LaFleur B, Sampath P. Anakinra for systemic juvenile arthritis: the rocky mountain experience. J Clin Rheumatol. 2009;15(4):161-64. [ Links ]
24. Church LD, McDermott MF. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther. 2009;11(1):81-89. [ Links ]
25. Giannini E, Ruperto N, Ravelli A, Lovell D. Preliminary definition of improvement in juvenile artritis. Arthritis Rheum. 1997;40(7):1202-1209. [ Links ]
26. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol. 2002;29(5):1058-1064. [ Links ]
Descargas
Publicado
2018-01-22
Cómo citar
Morel Ayala, Z. (2018). Artritis Idiopática Juvenil. Pediatría (Asunción), 36(3), 223-231. Recuperado a partir de https://www.revistaspp.org/index.php/pediatria/article/view/307
Número
Sección
Artículos de Revisión
Licencia
Todo el contenido de este sitio está bajo una Licencia de Atribución Creative Commons.
Todo el contenido de esta revista, está bajo 